Incomplete antibody evolution and seroreversion after treatment of primary HIV type 1 infection: what is the clinical significance?
Connick
Elizabeth
E
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans
D019380:Anti-HIV Agents; D015483:HIV Antibodies